Envisia Genomic Classifier

January 23, 2018January 23, 2018

Interstitial Lung Disease Diagnoses Usually Inaccurate, Emotionally Trying, Patient Survey Shows

A nationwide patient survey highlights the lengthy and often inaccurate diagnosis of interstitial lung disease (ILD), as well as the emotional stress it causes in patients. The research, “Barriers to ... Read more

December 5, 2017December 5, 2017

Veracyte Says Study Backs Up Usefulness of Envisia Genomic Classifier as IPF Diagnostic Tool

Idiopathic Pulmonary Fibrosis, News

Veracyte says new data confirming the analytical validity of its Envisia Genomic Classifier demonstrate its benefits in diagnosing idiopathic pulmonary fibrosis (IPF). The study, “Analytical performance of Envisia: a genomic classifier for ... Read more

November 17, 2017November 17, 2017

Veracyte’s Genomic Tool Aids in Diagnosing IPF Without Surgery, Real-world Data Suggests

Idiopathic Pulmonary Fibrosis

Veracyte presented early data from a real-world clinical test showing that its Envisia Genomic Classifier is an efficient tool for diagnosing idiopathic pulmonary fibrosis (IPF) without invasive and expensive surgery. ... Read more